Smith Wanli W, Smith Megan, Yang Dejun, Choi Pique P, Moghadam Alexander, Li Tianxia, Moran Timothy H
Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, United States of America.
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
PLoS One. 2015 Nov 16;10(11):e0142314. doi: 10.1371/journal.pone.0142314. eCollection 2015.
Previously, we have identified a novel role for the cytoplasmic protein, synphilin-1(SP1), in the controls of food intake and body weight in both mice and Drosophila. Ubiquitous overexpression of human SP1 in brain neurons in transgenic mice results in hyperphagia expressed as an increase in meal size. However, the mechanisms underlying this action of SP1 remain to be determined. Here we investigate a potential role for altered gut feedback signaling in the effects of SP1 on food intake. We examined responses to peripheral administration of cholecytokinin (CCK), amylin, and the glucagon like peptide-1 (GLP-1) receptor agonist, exendin-4. Intraperitoneal administration of CCK at doses ranging from 1-10 nmol/kg significantly reduced glucose intake in wild type (WT) mice, but failed to affect intake in SP1 transgenic mice. Moreover, there was a significant attenuation of CCK-induced c-Fos expression in the dorsal vagal complex in SP1 transgenic mice. In contrast, WT and SP1 transgenic mice were similarly responsive to both amylin and exendin-4 treatment. These studies demonstrate that SP1 results in a CCK response deficiency that may contribute to the increased meal size and overall hyperphagia in synphillin-1 transgenic mice.
此前,我们已确定细胞质蛋白α-突触核蛋白-1(SP1)在小鼠和果蝇的食物摄入及体重控制中具有新作用。在转基因小鼠的脑神经元中普遍过表达人SP1会导致摄食亢进,表现为进食量增加。然而,SP1这一作用的潜在机制仍有待确定。在此,我们研究肠道反馈信号改变在SP1对食物摄入影响中的潜在作用。我们检测了对胆囊收缩素(CCK)、胰淀素及胰高血糖素样肽-1(GLP-1)受体激动剂艾塞那肽-4外周给药的反应。腹腔注射剂量为1-10 nmol/kg的CCK可显著降低野生型(WT)小鼠的葡萄糖摄入量,但对SP1转基因小鼠的摄入量无影响。此外,在SP1转基因小鼠的迷走神经背核复合体中,CCK诱导的c-Fos表达显著减弱。相反,WT小鼠和SP1转基因小鼠对胰淀素和艾塞那肽-4治疗的反应相似。这些研究表明,SP1导致CCK反应缺陷,这可能是α-突触核蛋白-1转基因小鼠进食量增加和整体摄食亢进的原因。